Table of Content

1. Introduction



2. Research Methodology



3. Executive Summary



4. Market Dynamic
4.1 Growth Drivers
4.2 Challenges


5. Global Point of Care Diagnostics Market



6. Market Share
6.1 By Product
6.2 By Technology
6.3 By Mode of Prescription
6.4 By End Users
6.5 By Country


7. Product
7.1 Glucose Monitoring Kits
7.2 Infectious Diseases Kits
7.3 Pregnancy & Fertility Testing Kits
7.4 Haematology Testing Kits
7.5 Cardiometabolic Monitoring Kits
7.6 Urinalysis Testing Kits
7.7 Cholesterol Test Strips
7.8 Drugs Abuses Testing Kits
7.9 Others


8. Technology
8.1 Lateral Flow
8.2 Agglutination
8.3 Flow Through
8.4 Solid phase
8.5 Biosensor
8.6 Others


9. Mode of Prescription
9.1 Prescription-Based Devices
9.2 Over-the-counter (OTC)-Based Devices


10. End Users
10.1 Professional Diagnostic Centers
10.2 Research Laboratories
10.3 Home Care
10.4 Others


11. Country
11.1 North America

11.1.1 United States
11.1.2 Canada

11.2 Europe

11.2.1 France
11.2.2 Germany
11.2.3 Italy
11.2.4 Spain
11.2.5 United Kingdom
11.2.6 Belgium
11.2.7 Netherlands
11.2.8 Turkey

11.3 Asia Pacific

11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 South Korea
11.3.5 Thailand
11.3.6 Malaysia
11.3.7 Indonesia
11.3.8 Australia
11.3.9 New Zealand

11.4 Latin America

11.4.1 Brazil
11.4.2 Mexico
11.4.3 Argentina

11.5 Middle East & Africa

11.5.1 Saudi Arabia
11.5.2 UAE
11.5.3 South Africa


12. Porter’s Five Analysis
12.1 Bargaining Power of Buyers
12.2 Bargaining Power of Suppliers
12.3 Degree of Rivalry
12.4 Threat of New Entrants
12.5 Threat of Substitutes


13. SWOT Analysis
13.1 Strength
13.2 Weakness
13.3 Opportunity
13.4 Threat


14. Key Players Analysis
14.1 Sysmex
14.1.1 Overview
14.1.2 Recent Development
14.1.3 Financial Insights

14.2 Abbott Laboratories (US)
14.2.1 Overview
14.2.2 Recent Development
14.2.3 Financial Insights

14.3 Becton Dickinson and Company (US)
14.3.1 Overview
14.3.2 Recent Development
14.3.3 Financial Insights

14.4 Danaher Corporation (US)
14.4.1 Overview
14.4.2 Recent Development
14.4.3 Financial Insights

14.5 Quidel Diagnostics (US)
14.5.1 Overview
14.5.2 Recent Development
14.5.3 Financial Insights

14.6 F. Hoffmann-La Roche Ltd
14.6.1 Overview
14.6.2 Recent Development
14.6.3 Financial Insights

14.7 Thermo Fisher Scientific Inc.
14.7.1 Overview
14.7.2 Recent Development
14.7.3 Financial Insights

14.8 Bio-Rad Laboratories Inc.
14.8.1 Overview
14.8.2 Recent Development
14.8.3 Financial Insights



List of Figures

0

List of Tables

0